...
首页> 外文期刊>Journal of Clinical Microbiology >Detection of Streptococcus pneumoniae Antigen in Bronchoalveolar Lavage Fluid Samples by a Rapid Immunochromatographic Membrane Assay
【24h】

Detection of Streptococcus pneumoniae Antigen in Bronchoalveolar Lavage Fluid Samples by a Rapid Immunochromatographic Membrane Assay

机译:快速免疫色谱膜测定法检测支气管肺泡灌洗液样本中的肺炎链球菌抗原。

获取原文
           

摘要

We conducted a retrospective study to evaluate an immunochromatographic membrane test (ICT), applied to bronchoalveolar lavage (BAL) fluid samples obtained in patients with suspected pneumonia, for the detection of Streptococcus pneumoniae antigen. The NOW Streptococcus pneumoniae test was assessed on 96 BAL fluid samples. Sensitivity was tested in 20 samples obtained from patients diagnosed as having pneumococcal pneumonia (growth of S. pneumoniae in blood cultures and/or in BAL fluid samples of ≥104 CFU/ml). Specificity was tested in BAL fluid samples of nonpneumococcal etiology (n = 41) and in samples with no respiratory pathogen and a total bacterial count of <104 CFU/ml (n = 35). Using the ICT, pneumococcal antigen was detected in 29 (30.2%) BAL fluid samples, with a sensitivity of 95.0% (95% confidence interval [CI], 90.6% to 99.4%) and a specificity of 86.8% (95% CI, 80.1% to 93.8%). The ICT was easy to perform and revealed unequivocal and reproducible results. No interference was observed with high cell counts, red blood cells, or elevated protein levels. Four out of 10 false-positive readings occurred in samples with S. pneumoniae counts below the 104 CFU/ml threshold limit of pneumonia. In BAL fluid samples obtained after pneumococcal bacteremia, positive test results were found for up to 35 days after bacteremia. The ICT test applied to BAL fluid specimens is reproducible and accurate in the diagnosis of pneumococcal antigen. Further studies are required to establish the impact of the ICT on patient care.
机译:我们进行了一项回顾性研究,以评估对疑似肺炎患者获得的支气管肺泡灌洗液(BAL)进行免疫层析膜试验(ICT)的方法,以检测肺炎链球菌抗原。现在对96个BAL液体样本进行了肺炎链球菌检测。在从被诊断为肺炎球菌肺炎(肺炎链球菌在血液培养物中和/或在BAL液中≥10 4 CFU /的患者)中获得的20个样品中检测了敏感性毫升)。在非肺炎球菌病因( n = 41)的BAL液体样品中和没有呼吸道病原体且细菌总数<10 4 CFU / ml(< em> n = 35)。使用ICT,在29个(30.2%)BAL液体样本中检测到肺炎球菌抗原,灵敏度为95.0%(95%置信区间[CI],从90.6%至99.4%),特异性为86.8%(95%CI, 80.1%至93.8%)。 ICT易于执行,并显示出明确和可重复的结果。高细胞计数,红细胞或蛋白质水平升高均未观察到干扰。 10个错误阳性读数中有4个发生在具有 S的样品中。肺炎的计数低于肺炎的10 4 CFU / ml阈值限值。在肺炎球菌菌血症后获得的BAL液样本中,菌血症后长达35天都发现阳性测试结果。在肺炎球菌抗原诊断中,应用于BAL液体标本的ICT测试具有可重复性和准确性。需要进一步研究以确定ICT对患者护理的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号